Vir Biotechnology (VIR) Operating Leases (2020 - 2026)
Vir Biotechnology's Operating Leases came in at $84.14 million for Q2 2026, down 9.9% from $93.41 million a year earlier and down 2.9% from the prior quarter.
Powered by 
Analysis
Vir Biotechnology (VIR) Operating Leases (2020 - 2026) Analysis & Trends
At the end of FY2025, Vir Biotechnology's Operating Leases was $89.05 million, down 1.2% from FY2024.
- Operating Leases has declined in each of the last four years, though with a five-year compound annual growth rate of 6.0% (FY2020 to FY2025).
- Going back by year, Operating Leases was $90.14 million in FY2024 (-19.3%), $111.67 million in FY2023 (-9.8%), $123.84 million in FY2022 (-7.3%) and $133.56 million in FY2021 (+100.7%).
- The Q2 2026 figure represents the lowest quarterly Operating Leases since Q3 2021.
- Year-over-year, Operating Leases has declined for 15 consecutive quarters, with an average decline of 9.2% over the last eight quarters.
- The fastest year-over-year change in Operating Leases over five years came in Q3 2021 (growth of 467.4%), and the weakest in Q2 2024 (a decline of 19.3%).
- Business Quant data shows VIR's Operating Leases at $86.64 million (Q1 2026), $89.05 million (Q4 2025) and $91.22 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,130.22 Bn | 1,098.81 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 613.62 Bn | 532.15 Bn | 17.26 Bn |
| 3 | AbbVie | 501.46 Bn | 474.57 Bn | 12.70 Bn |
| 4 | Merck | 366.84 Bn | 321.22 Bn | 12.21 Bn |
| 5 | Novartis Ag | 297.85 Bn | 261.84 Bn | 11.24 Bn |
| 6 | Astrazeneca | 261.66 Bn | 235.34 Bn | 12.86 Bn |
| 7 | Amgen | 235.39 Bn | 190.79 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 190.66 Bn | 164.86 Bn | 6.22 Bn |
| 9 | Pfizer | 169.57 Bn | 116.22 Bn | 10.94 Bn |
| 10 | Vir Biotechnology | 1.82 Bn | -138.05 Mn | 238.95 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 84.14 Mn |
| Mar 31, 2026 | 86.64 Mn |
| Dec 31, 2025 | 89.05 Mn |
| Sep 30, 2025 | 91.22 Mn |
| Jun 30, 2025 | 93.41 Mn |
| Mar 31, 2025 | 88.17 Mn |
| Dec 31, 2024 | 90.14 Mn |
| Sep 30, 2024 | 93.41 Mn |
| Jun 30, 2024 | 95.02 Mn |
| Mar 31, 2024 | 109.17 Mn |
| Dec 31, 2023 | 111.67 Mn |
| Sep 30, 2023 | 114.12 Mn |
| Jun 30, 2023 | 117.82 Mn |
| Mar 31, 2023 | 121.46 Mn |
| Dec 31, 2022 | 123.84 Mn |
| Sep 30, 2022 | 126.94 Mn |
| Jun 30, 2022 | 130.21 Mn |
| Mar 31, 2022 | 132.81 Mn |
| Dec 31, 2021 | 133.56 Mn |
| Sep 30, 2021 | 68.60 Mn |
API Access
Vir Biotechnology Operating Leases API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=operating-leases&ticker=VIR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "operating-leases", "ticker": "VIR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=operating-leases&ticker=VIR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();